LEP and obesity due to melanocortin 4 receptor deficiency: Chronic administration of JTT-551 to mice with diet-induced obesity showed anti-obesity effects, improved resistance to leptin and lipid disorders, and may also mediate glucose metabolism abnormalities [32].